tellmeGen vs 23andMe: Smaller Brand, Bigger Bundle?
tellmeGen bundles ancestry, traits, carrier, and health-predisposition reports at one price. 23andMe ships FDA-authorized reports. We compare what you get for the money.
tellmeGen sells an Advanced DNA Test that bundles ancestry, traits, carrier-status, and health-predisposition reporting at a single price. 23andMe is the established American brand with a roughly 14 million-user matching database and a defined set of FDA-authorized health reports. The two are sometimes shopped against each other by buyers who want “ancestry plus health” in a single purchase without paying a premium for the bigger brand name. We think the honest comparison is more interesting than the marketing on either side.
A heads-up before specifics: 23andMe’s corporate status is unstable following its March 2025 Chapter 11 filing and the mid-2025 sale of assets to TTAM Research Institute. Pricing and the affiliate program are moving targets; the consumer test still operates. Our genetic data privacy guide covers the implications.
At a glance
| Spec | tellmeGen | 23andMe |
|---|---|---|
| Test method | Autosomal SNP genotyping | Autosomal SNP genotyping |
| Bundle | Ancestry + traits + carrier + health predisposition in one tier | Ancestry-only or Ancestry + Health tiers |
| Pricing | Verify directly on tellmeGen (single bundled price) | Historically about $119 ancestry, $199+ ancestry + health; verify |
| Health reports | Carrier and predisposition reports (company-generated) | FDA-authorized carrier and predisposition reports plus non-authorized reports |
| Database | Not a primary matching-database product | About 14 million users |
| Accepts raw uploads | Yes | No |
| Regions (as of early 2026) | US, EU, others | US, CA, UK, others |
| Status | Active | Verify |
The short answer
If you want a single bundled price for ancestry plus health-style reports and you don’t need a large matching database, tellmeGen is worth a serious look. If you specifically want FDA-authorized health reports and the largest combined ancestry-plus-health user base, 23andMe is the established choice and you accept the post-bankruptcy uncertainty as part of the deal.
Report breadth: where tellmeGen’s pitch holds up
The thing tellmeGen does well is package. The Advanced test bundles several categories of report into one purchase: ancestry composition, traits (the lighter “do you have a cilantro aversion” category), carrier-status reports, and health-predisposition reports. Buyers who would otherwise pay separately for ancestry and health like the single ticket price.
23andMe used to bundle similarly under “Health + Ancestry” but its post-bankruptcy product line should be confirmed on the live site. Pre- bankruptcy, the bundled tier ran about $199 and the ancestry-only tier about $99, with sale pricing seasonally.
Regulatory standing differs
23andMe holds FDA authorizations for a specific list of carrier-status and genetic-health-risk reports. Not every 23andMe health report is FDA- authorized; the authorized list is narrower than the overall catalog. The authorized reports carry clinical weight that company-generated reports without that authorization do not.
tellmeGen’s health-predisposition reports are the company’s reports based on the variants in your sample. They are not FDA-authorized in the same way. Useful, often interesting, but a different category. For any result that prompts concern, route to the NSGC directory and have a credentialed counselor walk you through it.
Database matters if you want relatives
23andMe runs a relative-matching database of roughly 14 million users (down from about 15 million pre-2023 breach, per industry trackers). tellmeGen does not lead with matching; if finding genetic relatives is your main goal, you are not shopping for tellmeGen at all. You want AncestryDNA or 23andMe or MyHeritage for that purpose.
tellmeGen’s value in the matching department comes from a different direction: it accepts uploads of raw data from other tests, so you can read existing ancestry results in tellmeGen’s interface alongside its health reports.
Regional availability and brand familiarity
tellmeGen ships across Europe and to the US, with stronger European presence than American brand recognition. 23andMe is the household name in the US, UK, Canada, and several other markets. If your relatives are likely to have tested somewhere, in 2026 that somewhere is more likely AncestryDNA or 23andMe than tellmeGen.
Honest take on the smaller-brand trade-off
Smaller brand does not mean worse science. It does mean fewer users have tested, fewer reviews exist, less third-party scrutiny has happened, and support volume is lower. Read recent buyer feedback on shipping, turnaround, and customer service for your country specifically before ordering tellmeGen, because the experience varies more than 23andMe’s does across regions. Turnaround for tellmeGen carries a verify flag in our data set; confirm it on the merchant page.
Who should pick tellmeGen
Buyers who want ancestry plus several health-style report categories at a single bundled price, who don’t need a large relative-matching database, and who are comfortable with a smaller brand. EU buyers especially.
Who should pick 23andMe
Buyers who want FDA-authorized health reports, the larger combined ancestry-and-health database, and the more established US brand, and who accept the post-bankruptcy corporate uncertainty as part of the deal.
Verdict
The breadth-versus-regulatory-weight trade-off is real here. tellmeGen bundles more report categories per ticket price; 23andMe brings FDA- authorized reports and a 14 million-user matching database. Either way, nothing in either report set substitutes for a conversation with a credentialed genetic counselor about anything health-relevant.
Related reading: SelfDecode vs 23andMe for health, 23andMe vs AncestryDNA for health, DNA test comparisons.